← Top Holdings
RAREUltragenyx Pharmaceutical In
CUSIP: 90400D108
No superinvestors currently hold this stock.
📊 Fundamentals
Market Cap$2.6B
Forward P/E8.6x
EPS (TTM)$-6.10
Revenue (TTM)$670.0M
Profit Margin-90.90%
Beta0.31
52-Week Range
$18.29
$39.89
Current: $26.90
Data from Yahoo Finance · refreshed every 4 hours
📊 Holdings Over Time
How superinvestor ownership has changed across quarters
Quarter-by-Quarter Activity
Q1 '251 owners · $3.1M
No changes
Q4 '241 owners · $3.6M
No changes
Q3 '241 owners · $4.7M
No changes
💰 DCF Calculator
DCF model · 10-yr forecastEstimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.
⚠️ This company currently has negative free cash flow. The valuation assumes it will improve.
📊 Adjust the assumptions below to calculate an estimated fair value
Projection Period
Revenue Growth Rate
32%analyst est. 32.4%
0%100%
Growth Decay Rate
15%
0% (no decay)50% (fast decay)
Terminal Growth Rate
3.0%
0%5%
FCF Margin
5.0%current: -32.7%
1%50%
Discount Rate (WACC)
8.0%typical: 8% large caps · 10% growth
5%20%
Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data
🏛️ Congressional Trades
RARE: Held by 0 superinvestors · 6 congress member trades
$1,001 - $15,0002026-03-03
$1,001 - $15,0002026-02-18
$1,001 - $15,0002025-08-08
$1,001 - $15,0002025-08-08
$1,001 - $15,0002025-07-15
$1,001 - $15,0002025-07-15